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We recently established a key role for host sphingomyelin synthase (SMS) in regulating
the killing activity of neutrophils against Cryptococcus neoformans. In this paper, we stud-
ied the effect of C. neoformans on the killing activity of neutrophils and whether SMS
would still be a player against C. neoformans in immunocompromised mice lacking T and
natural killer (NK) cells (Tgε26 mice). To this end, we analyzed whether C. neoformans
would have any effect on neutrophil survival and killing in vitro and in vivo. We show that
unlike Candida albicans, neither the presence nor the capsule size of C. neoformans cells
have any effect on neutrophil viability. Interestingly, melanized C. neoformans cells totally
abrogated the killing activity of neutrophils. We monitored how exposure of neutrophils
to C. neoformans cells would interfere with any further killing activity of the conditioned
medium and found that pre-incubation with live but not “heat-killed” fungal cells signiﬁ-
cantly inhibits further killing activity of the medium.We then studied whether activation of
SMS at the site of C. neoformans infection is dependent on T and NK cells. Using matrix-
assisted laser desorption–ionization tissue imaging in infected lung we found that similar
to previous observations in the isogenic wild-type CBA/J mice, SM 16:0 levels are signiﬁ-
cantly elevated at the site of infection in mice lackingT and NK cells, but only at early time
points.This study highlights that C. neoformans may negatively regulate the killing activity
of neutrophils and that SMS activation in neutrophils appears to be partially independent
of T and/or NK cells.
Keywords: neutrophils, sphingolipid, sphingomyelin, immunodeficient mice, fungal infection, Cryptococcus
neoformans
INTRODUCTION
The fact that an infection caused by Cryptococcus neoformans still
cannot be fully contained by the host is starkly evident. Almost
all reviews on host defense against the ubiquitous environmen-
tal fungus emphasize the role of cell-mediated immunity (CMI),
which is critical for containment of fungal cells through the acti-
vation of macrophages and neutrophils, resulting in granuloma
formation (Huffnagle et al., 1991a,b; Goldman et al., 1994).While
there are several studies elucidating the role and mechanisms by
which alveolar macrophages control a C. neoformans infection
(Feldmesser et al., 2001; Luberto et al., 2003; Fan et al., 2005;
Shao et al., 2005; Alvarez and Casadevall, 2006; Ma et al., 2006;
Rittershaus et al., 2006; Garcia et al., 2008; Stano et al., 2009),
very little is known on the mechanisms by which neutrophils
neutralize C. neoformans. Neutrophils are more effective killers
than macrophages against fungi (Diamond et al., 1972; Miller and
Mitchell, 1991) and they possess the innate ability to kill microbes
without a CMI-mediated activation. We have recently shown that
host sphingomyelin synthase (SMS) plays a pivotal role in the
regulation of the killing activity of neutrophils against C. neo-
formans through a diacylglycerol-protein kinase D (DAG-PKD)
dependent mechanism (Qureshi et al., 2010). In order to fur-
ther understand the cryptococcal–neutrophil interaction, we have
undertaken additional studies utilizing the HL-60 cell line model
system and a mouse model lacking T and natural killer (NK)
cells (Tgε26) to gain a better understanding of this important
relationship in protecting the host.
MATERIALS AND METHODS
MATERIALS, STRAINS, AND GROWING MEDIA
Cryptococcus neoformans variety grubii serotype A strain H99
(WT), Candida albicans strain A39, and Saccharomyces cerevisiae
JK9-3dα (WT) were routinely grown in yeast extract/peptone/2%
dextrose-rich (YPD-rich) medium. C. neoformans Δgsc1 and
Δisc1 mutant strains were created previously in our laboratory
(Heung et al., 2005; Rittershaus et al., 2006; Shea et al., 2006).
C. neoformans GAL7::IPC1 strain was created from M001, an
ade2 isogenic strain derivative of H99, as described previously
(Luberto et al., 2001). Melanized strain H99 was grown on BD
BBL™Stacker™bird seed agar plates (cat. 297875). HL-60 cells
(ATCC® CCL-240™) were cultured at 37˚C, 5% CO2 in RPMI
1640, supplemented with l-glutamine, 20% heat-inactivated FBS,
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and 1% penicillin and streptomycin. RPMI 1640 medium, FBS,
and penicillin–streptomycin were from Gibco/Invitrogen; pooled
human serum, retinoic acid, and DMSO were from Sigma.
HL-60 VIABILITY ASSAY
Toquantify the effect ofC. neoformans,C. albicans, and S. cerevisiae
on neutrophils, HL-60 cells were differentiated by incubation in
the presence of 1.3%(v/v)DMSOand2.5μMretinoic acid for 72 h
in growthmedium. Cells were then washed with RPMI serum-free
medium and 8× 104 granulocytes/ml re-suspended in fresh RPMI
containing 10% pooled human serum. These were co-cultured
with 4× 103 C. neoformans,C. albicans, or S. cerevisiae (20:1 ratio
HL-60:yeast)/ml for 24 h at 37˚C. At time points speciﬁed in the
Section “Results,” HL-60 cells were counted using trypan blue to
determine their viability.
HL-60 MEDIUM KILLING ASSAY
To quantify the effect of HL-60 medium on C. neoformans, the
killing assay described by Spellberg et al. (2007) was used. HL-
60 cells were differentiated by incubation in the presence of 1.3%
(v/v) DMSO and 2.5μMretinoic acid for 72 h in growthmedium.
Cells were then washed with RPMI serum-free and 8× 104 neu-
trophils/ml re-suspended in fresh RPMI containing 10% pooled
human serum for 1,2,4,6,8, and 16 h.Conditionedmedia (900μl)
were then collected by centrifugation and 4× 103 cells/ml C. neo-
formans (20:1 ratio HL-60:C. neoformans) incubated for 4 h at
37˚C.At the end of the incubation, themediumwas serially diluted
and streaked onto YPD agar, and the plates incubated for 48 h at
30˚C. CFUs were counted to assess killing of C. neoformans com-
pared with control cultures of C. neoformans alone with no HL-60
medium. In order to check the effect of pre-incubatingHL-60 cells
with “heat-killed” C. neoformans, 4× 103 C. neoformans cells/ml
were boiled at 100˚C for 10min prior to addition to HL-60.
EFFECT OF PRE-INCUBATION WITH C. NEOFORMANS ON HL-60D
MEDIUM KILLING ACTIVITY
In order to examine the effect of pre-incubating HL-60 cells with
C. neoformans prior to removing the conditioned HL-60 medium
for further experimentation, 8× 104 neutrophils/ml were incu-
bated with 4× 103 C. neoformans H99 cells/ml for 1, 2, 4, and
6 h. At the speciﬁed time points, a portion of the cells were seri-
ally diluted and streaked onto YPD agar, and incubated for 48 h
at 30˚C. CFUs were counted to assess killing of C. neoformans at
the various time points. At the same time, the remainder of the
cells was centrifuged and the conditioned medium (800μl) trans-
ferred to fresh wells. About 4× 103 fresh C. neoformans cells/ml
were then added and allowed to incubate for a further 4 h at 37˚C.
At the end of the incubation, the medium was serially diluted and
streaked ontoYPD agar, and incubated for 48 h at 30˚C. CFUswere
counted to assess killing of C. neoformans compared with control
cultures of C. neoformans alone with no HL-60 medium.
EFFECT OF CAPSULE ON KILLING OF C. NEOFORMANS BY
DIFFERENTIATED HL-60 (HL-60D)
Cryptococcus neoformans WT H99 and Δcap59 were used for cap-
sule growth experiments. The yeast cells were grown overnight in
10mlYPD at 30˚Cwith shaking, collected in the logarithmic phase
of growth by centrifugation (10min at 3000 rpm at room temper-
ature), washed twice with phosphate-buffered saline (PBS), and
then incubated at a cell density of 5× 106 cells/ml in the capsule
growth inducing medium (DMEM buffered with 25mM HEPES
pH 7.2) overnight at 37˚C, 5% CO2. HL-60D cells were washed
with RPMI and 8× 104 cells/ml re-suspended in fresh RPMI sup-
plementedwith 10%pooledhuman serumand incubated for 6 h at
37˚C, 5%CO2. Conditionedmedia (900μl) were then collected by
centrifugation and 4× 103 cells/ml C. neoformans H99 or Δcap59
added and allowed to incubate for 4 h at 37˚C. At the end of the
incubation, the medium was serially diluted and streaked onto
YPD agar, and incubated for 48 h at 30˚C. CFUs were counted to
assess killing of C. neoformans compared with control cultures of
C. neoformans alone with no HL-60 medium.
EFFECT OF MELANIN ON KILLING OF C. NEOFORMANS BY HL-60D
MEDIUM
Following differentiation, HL-60D cells were washed with RPMI
and 8× 104 cells/ml re-suspended in fresh RPMI supplemented
with 10% pooled human serum and incubated for 6 h at 37˚C, 5%
CO2. Conditionedmedia (900μl) were then collected by centrifu-
gation and 4× 103 melanized or non-melanized C. neoformans
cells/ml added and allowed to incubate for 4 h at 37˚C. At the end
of the incubation, the medium was serially diluted and streaked
ontoYPD agar, and incubated for 48 h at 30˚C. CFUswere counted
to assess killing of melanized vs non-melanized C. neoformans.
NEUTROPHIL KILLING ASSAY
Approximately 1.6× 105 freshly isolated murine neutrophils/ml
were incubated in 124ml sterile ﬁltered PBS supplemented with
10% pooled mouse serum for 4 h in the presence of 9.92× 104 C.
neoformans cells/ml (10μl used; 20:1 ratio murine neutrophils:C.
neoformans). At the end of the incubation, the cultures were seri-
ally diluted and streaked onto YPD agar, and incubated for 48 h
at 30˚C. CFUs were counted to assess killing of C. neoformans
compared with control cultures of C. neoformans alone with no
neutrophils. Murine neutrophils were obtained from Tgε26 mice
using the method of Shimizu et al. (2001) with the following
modiﬁcations. Following harvest of the cells and a single wash
with PBS, the collected cells were re-suspended in 4ml PBS and
neutrophils separated from mononuclear cells using 3ml Ficoll-
Paque™PREMIUM (GE Healthcare, cat. 17-5442-02). The mix-
ture was centrifuged at 400×g for 40min at 20˚C. The resulting
pellet was collected and red blood cells were lysed with 5ml ice-
cold water in ice for 1min. Cold PBS (10ml) was then added and
the mixture centrifuged at 400×g for 10min at 4˚C. The result-
ing pellet was then re-suspended in 500μl PBS. Mouse sera were
obtained from Tgε26 mice.
ANIMAL STUDIES
Four- to six-week-old Tgε26 mice from the Animal Core Facility,
Medical University of South Carolina, Charleston, were used for
this study. Mice were anesthetized by intraperitoneal injection of
60μl of a xylazine–ketamine mixture containing 5mg xylazine
and 95mg ketamine per kg of body weight. The wild-type strain
(H99) of C. neoformans was grown in YPD medium for 24 h at
30˚C. The fungal cells were harvested, washed three times in PBS,
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and re-suspended in PBS at a concentration of 2.5× 107 cells/ml.
Micewere infected intranasally with 20μl containing 5× 105 cells.
Mice were fed ad libitum andmonitored by inspection twice a day.
Mice that appeared moribund or in pain were sacriﬁced using
CO2 inhalation followed by cervical dislocation. All animal proce-
dures were approved by the Medical University of South Carolina
Institutional Animal Care and Use Committee and followed the
guidelines of the American Veterinary Medical Association.
TISSUE SECTIONING AND SAMPLE PREPARATION
At 6, 12, and 15 days post-infection, mice were euthanized and
lungs were harvested and ﬂash-frozen in dry-ice/ethanol, then
stored at −80˚C until ready for use. The organ was attached to
the cryostat sample stage using a small bead of optimal cutting
temperature compound (OCT) at the base of the tissue only. The
tissue was sectioned to a thickness of 30μm at a temperature
of −26˚C using a cryotome (Microm HM 550, Walldorf, Ger-
many). The sections were thaw-mounted onto conductive indium
tin oxide (ITO) coated conductive glass slides for mass spectral
analysis (Bruker Daltonics, Billerica, MA, USA). The resistance
of the ITO coated microscope slide was 40Ω over a distance of
1 cm. The tissue was allowed to warm on the microscope slides
for 10 s before refreezing and storage at −80˚C. For mass spectro-
metric analysis, the tissue sections were removed from the freezer
and placed in a dessicator for 30min prior to matrix deposition.
A freshly prepared solution of 2,5-dihydroxybenzoic acid (DHB;
Sigma; 40mg/ml in 70% ethanol), was applied to the tissue by
repeated cycles using a thin layer chromatography (TLC) sprayer.
Each spray cycle was followed by 45–60 s of drying time, and the
cycle repeated until an even coverage of matrix across the entire
tissue was achieved.
MALDI mass spectrometry SM imaging
Matrix-assisted laser desorption–ionization (MALDI) mass spec-
tral analysis was carried out using a reﬂector time-of-ﬂight mass
spectrometer (Bruker Autoﬂex III TOF-TOF, Bruker Daltonik,
Bremen,Germany) operating in positive ionmode with a +20-kV
accelerating potential. The laser beam size was set to medium, and
operated at 200Hz. Using Bruker Peptide Standard 1 (Bruker Dal-
tonik,Bremen,Germany), a linear, external calibrationwas applied
to the instrument before data collection. Mass spectral data sets
were acquired over each whole mouse lung using ﬂexImaging™-
software (Bruker Daltonik, Bremen, Germany) in the mass range
of m/z 500–1200 with a raster step size of 100μm and 250 laser
shots per spectrum. After data acquisition, molecular images were
reconstituted using ﬂexImaging™software. Each data set consists
of approximately 4000 individual sampling locations, each rep-
resenting one pixel in the resultant image. Data was normalized
using ﬂexImaging™software, and each m/z signal plotted± 0.5
mass units. For display purposes, signals between sampling loca-
tions were interpolated and pixel intensities were scaled to utilize
the entire dynamic range. Tandem mass spectrometry was used
to identify signals detected in the MALDI imaging data sets.
Lipids to be identiﬁed were extracted from mouse lung tissue by
homogenization of the tissue in 70% ethanol. Samples were cen-
trifuged at 45,000 rpm for 30min at 4˚C using a Beckman Optima
TL Ultracentrifuge with a TLA45 rotor (Beckman Coulter, Inc.,
Fullerton, CA, USA), and the supernatant containing extracted
lipids removed. Samples were concentrated using a speed-vac
(Labconco, Kansas City, MO, USA), and spotted on a MALDI
plate using 40mg/ml DHB in 70% ethanol. Standard solutions
of known lipids were also spotted in a similar manner. A timed
ion gate was used for precursor ion selection and the fragments
generated were further accelerated with 19 kV in the LIFT cell,
and detected following passage through the reﬂectron. No CID
gas was used for fragmentation of the precursor ions. Signals in
theMALDI tissue imagingdata setwere identiﬁedbasedonmatch-
ing fragmentation spectra of lipids extracted from the tissue and
prepared lipid standard solutions.
SM DETERMINATION
For lipid analysis in lung tissues, lungs from two mice from each
time point were homogenized in 5ml homogenization buffer con-
sisting of 0.25M sucrose, 0.5mM EDTA, 25mM KCl, and 50mM
Tris–HCl at pH 7.4. Then, 1mg of homogenate was used for the
mass spectrometry analysis at theMedicalUniversity of SouthCar-
olina Lipidomics Facilitywhereas an aliquotwas used for the quan-
titation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH;
Qureshi et al., 2010) by Western blot using the LabWorks Image
Acquisition andAnalysis software fromUVP BioImaging Systems,
version 4.5. Lipids were extracted and analyzed using established
protocols in the facility (Bielawski et al., 2006, 2009).
Statistics
All experiments were performed at least in triplicate. Statistical
analyses of the data were performed using Student’s t -test, and
P < 0.05 was considered statistically signiﬁcant.
RESULTS
CRYPTOCOCCUS NEOFORMANS DOES NOT AFFECT THE VIABILITY OF
HL-60D CELLS
To determine the fate of HL-60 granulocytes exposed to C. neofor-
mans, the viability of the granulocytes was determined at 1, 2, 3,
4, 5, 6, and 24 h following co-incubation with C. neoformans cells
at a ratio of 20:1 (HL-60D:C. neoformans). As a comparison, C.
albicans, which is known to affect viability (Mullick et al., 2004),
was used as a positive control. Figure 1 shows that C. albicans
induced a signiﬁcant level of mortality starting at 2 h in the HL-60
cells whereas C. neoformans did not. In contrast to C. albicans, but
similar to C. neoformans, S. cerevisiae does not elicit a mortality
response in HL-60.
KILLING ACTIVITY OF NEUTROPHILS IS SOLELY DUE TO SECRETED
FACTORS
In order to determine the optimal time point for incubation of
differentiated HL-60 cells in fresh medium prior to exposure to
C. neoformans, following differentiation 8× 104 granulocytes/ml
were incubated in fresh RPMI medium containing 10% human
serum for 1, 2, 4, 6, 8, and 16 h. The medium was then collected
by centrifugation at 3000 rpm for 10min and 4× 103 C. neofor-
mans cells/ml added and incubated for 4 h at 37˚C. Figure 2 shows
that the percentage killing of C. neoformans was greatest at 6 h
of incubation of differentiated HL-60 (HL-60D) in fresh medium
and that the killing effect diminishes after this time. However the
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FIGURE 1 | Cryptococcus neoformans does not affect HL-60D viability.To quantify the effect of co-incubation, differentiated HL-60 cells (HL-60D) were
incubated either alone or with C. neoformans WT (H99), C. albicans A39, or S. cerevisiae JK9-3dα. C. albicans affects viability of HL-60 cells whereas
S. cerevisiae or C. neoformans do not.
FIGURE 2 |Time course of the killing activity of neutrophils against
C. neoformans. Six hours is the peak for the killing of HL-60D in fresh
medium (10% HS+RPMI) prior to exposure to live C. neoformans.
Incubation with heat-killed C. neoformans (up to 6 h) has no effect on the
down-stream killing activity of the conditioned medium.
presence of heat-killed C. neoformans has no effect on the down-
stream killing activity of the conditioned medium. Together with
the results shown in Figure 1 in which viability of HL-60D at 6 h
is not reduced, it appears that the killing of C. neoformans is solely
due to secreted anti-cryptococcal factors (ACFs) by HL-60D.
PRE-INCUBATION OF DIFFERENTIATED HL-60 (HL-60D) CELLS WITH LIVE
C. NEOFORMANS SIGNIFICANTLY INHIBITS ANY FURTHER KILLING
ACTIVITY OF HL-60D MEDIUM
We next wished to test the effect of pre-incubation with C. neofor-
mans on the killing ability of HL-60D medium (Figure 3). To
this aim, following a 72-h incubation with 1.3% (v/v) DMSO
and 2.5μM retinoic acid as described above, 8× 104 cells were
FIGURE 3 | Pre-incubation of HL-60D cells with C. neoformans
significantly inhibits further killing activity of HL-60D medium.
Pre-incubation with C. neoformans decreases any further killing of
anti-cryptococcal factors in HL-60D medium.
washed, re-suspended in 1ml fresh RPMI containing 10% pooled
human serum and incubated with 4× 103 C. neoformans cells
for 1, 2, 4, and 6 h. At each time point, the killing activity was
determined by counting CFUs and comparing to control cul-
tures of C. neoformans alone with no HL-60 cells. At the same
time, 800μl of conditioned medium containing ACFs was col-
lected by centrifugation at each time point and incubated with
4× 103 fresh C. neoformans cells/ml for a further 4 h at 37˚C.
It was found that pre-incubation of HL-60D cells with C. neo-
formans decreases further killing ability of the ACFs in HL-60D
medium.
EXTENT OF C. NEOFORMANS KILLING BY HL-60D IS NOT RELATED TO
CAPSULE SIZE BUT IS RELATED TO MELANIN PRODUCTION
Since C. neoformans factors are able to neutralize the killing activ-
ity of the medium we sought to examine the effect of capsule
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and melanin on the killing activity of the conditioned medium
collected from HL-60D. C. neoformans produces a polysaccha-
ride capsule, which consists of glucuronoxylomannan (GXM) and
galactoxylomannan (GalXM), aswell asmannoprotein (Bose et al.,
2003). These components all occupy spatially separate and dis-
crete regions in the capsule of C. neoformans (Jesus et al., 2010).
Surprisingly the presence of capsule made no difference to the
killing activity of HL-60D medium (Figure 4A), in line with pre-
vious ﬁndings suggesting that the extent to which different C.
neoformans strains (capsular and acapsular) were killed by neu-
trophils was not consistently related to the size of the capsule
or the entire cell (Miller and Mitchell, 1991). In order to deter-
mine the effect of HL-60D medium on the killing of melanized
vs non-melanized C. neoformans, HL-60 granulocytes were incu-
bated with melanized H99 for 4 h. Melanin has been shown to
interfere with numerous host defense mechanisms, and it is well
known that melanized C. neoformans cells are less susceptible to
the toxic effects of microbicidal peptides than non-melanized
cells (Doering et al., 1999). In addition, melanization protects
C. neoformans against injury secondary to nitrogen or oxygen
derived radical attack (Nosanchuk and Casadevall, 2003, 2006).
In accordance with this, Figure 4B shows that HL-60D medium
is unable to kill melanized C. neoformans, with no cell death
observed suggesting that melanin totally protects C. neoformans
from the killing activity of the conditionedmedium collected from
HL-60D.
FUNGAL INOSITOL SPHINGOLIPIDS AND GLUCOSYLCERAMIDE
CONTENT AFFECT C. NEOFORMANS SUSCEPTIBILITY TO NEUTROPHILS
Fungal inositol containing sphingolipids have been implicated in
the regulation of the sensitivity of C. neoformans to oxidative and
nitrosative stresses (Shea et al., 2006). At the same time, gluco-
sylceramide is essential for fungal growth in host extracellular
environments (Rittershaus et al., 2006). Interestingly, intracellu-
lar growth is regulated by a different sphingolipid (phytoceramide
C26) which is mainly produce by Isc1. We therefore wished to
investigate whether the HL-60D medium killing of C. neoformans
correlated with the amount of complex sphingolipids present in
the H99 strain. In order to test this, we used C. neoformans WT
H99, Δgcs1, GAL7::IPC1, and Δisc1 mutant strains, each having a
different “ﬁtness” compared to the WT strain. The Δgcs1 mutant
stain was included in the study as it shows no growth defect in
the intracellular environment, compared to Δisc1 which grows
poorly at low pH and is susceptible to intracellular compounds
such as nitric oxide and hydrogen peroxide. Following incubation
of these strains for 4 h with HL-60D medium, they were streaked
onto YPD agar plates and CFUs counted after 48 h incubation at
30˚C. We found that the GAL7::IPC1 cells, in which the level of
inositol sphingolipids compared to the WT is decreased (Luberto
et al., 2001),were signiﬁcantly less susceptible to the killing activity
of HL-60D medium compared to WT cells (Figure 5). Similarly,
the glucosylceramide-lacking strain (Δgcs1) was slightly more
resistant (although not signiﬁcant) to the killing activity of the
FIGURE 4 | Effect of C. neoformans capsule and melanin on neutrophils
killing activity. (A) Capsule size does not affect HL-60D killing ability. The
acapsular strain Δcap59 has no capsule, but is more resistant to killing by
HL-60D, presumably due to its thicker cell wall. (B) Non-melanized
C. neoformans is killed by HL-60D whereas melanin confers resistance
against anti-cryptococcal factors.
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FIGURE 5 | Fungal inositol sphingolipids and glucosylceramide content
affect C. neoformans susceptibility to neutrophils. Decrease in inositol
sphingolipids (GAL7::IPC1) compared toWT seems to confer resistance to
killing. Lack of glucosylceramide (Δgcs1) is not signiﬁcantly more resistant
to killing. Δisc1 accumulates inositol sphingolipids and lacks phytoceramide
C26 but it is as sensitive to killing asWT.
medium. Interestingly, the Δisc1 mutant which accumulates inos-
itol sphingolipids (Henry et al., 2011) was as sensitive to the killing
as the wild-type (Figure 5).
NEUTROPHILS FROM IMMUNOCOMPROMISED Tgε26 MICE KILL C.
NEOFORMANS
Since cryptococcosis is an opportunistic fungal disease often seen
in patients with impaired cellular immunity such as acquired
immunodeﬁciency syndrome (AIDS), and since the host defense
is regulated by CMI (Lim and Murphy, 1980) where CD4+ T cells
play a central role in limiting infection (Hill and Harmsen, 1991;
Huffnagle et al., 1991a;Kawakami,2002;Uezu et al., 2004),wewere
interested in studying whether neutrophils from an immunocom-
promised host lacking NK and T cells would still be able to kill C.
neoformans.Wehadpreviously observed that neutrophils obtained
from immunocompetent mice having a fully functional immune
system were able to kill C. neoformans (Qureshi et al., 2010). To
this aim, we employed fresh murine neutrophils from Tgε26 mice,
and carried out the killing assay as described in the Section“Mate-
rials and Methods”. It was found that these mouse neutrophils kill
C. neoformans even though they lack NK and T cells (Figure 6).
SPHINGOMYELIN 16:0 IN LUNGS OF MICE LACKING NK AND T CELLS IS
UPREGULATED WHEN MICE ARE INFECTED WITH C. NEOFORMANS
Matrix-assisted laser desorption/ionization-mass spectrometric
imaging (MALDI–MSI) allows the visualization of the spatial dis-
tribution of speciﬁc molecules according to their m/z ratio within
thin sections of tissue. The identiﬁcation of the imaged lipid was
accomplished by MALDI tandem mass spectrometry where frag-
mentation patterns were compared to those of sphingomyelin
standards (see Materials and Methods). In our previous studies
we showed that killing activity of neutrophils is mediated by SMS
activity, and that there is a differential distribution of SM species
as observed by MALDI–MSI. It is known that infection by C. neo-
formans mainly occurs in immunodeﬁcient subjects, particularly
FIGURE 6 | Effect of freshly isolated murine neutrophils from
immunocompromised host on C. neoformans. Neutrophils from both
immunocompromisedTgε26 mice as well as immunocompetant CBA/J
mice display the ability to kill C. neoformans, even thoughTgε26 mice lackT
and NK cells.
those in which T cells count is drastically low (e.g., HIV positive
subjects; Kovacs et al., 1985; King and Dewitt, 2010). Since we
found that neutrophils isolated from the Tgε26 mice are able to
killC. neoformans very efﬁciently (Figure 6), and in previous stud-
ies we found that this killing ability is mediated by SMS activity
(Qureshi et al., 2010), it was important to determine whether SMS
activity would also have a role against C. neoformans under con-
ditions of T cell deﬁciency. Thus, we examined the distribution
of SM (as a read-out of SMS activity) species in C. neoformans-
infected vs un-infected lung of Tgε26 mice. Overall, we found
that SM 16:0 was distributed more homogenously in Tgε26 com-
pared to CBA/J infected lungs (Figure 7). However, SM 16:0 was
still clustered around the site of C. neoformans infection where an
intense neutrophil inﬁltration was observed especially at day 15
of infection, although it was much less organized than what we
observed in CBA/J lungs (Figure 7).
LIPID ANALYSIS BY HPLC-MS/MS
Since we found that SM 16:0 was elevated in the lungs of Tgε26
mice, we wondered whether any other subspecies of SM not
observed by MALDI–MSI would also be elevated. To address this
question, we examined the level of different species of SM, such
as 16:0, 18:0, 18:1, 20:0, 20:1, 22:0, 22:1, 24:0, and 24:1 in lung of
Tgε26 infected mice. As expected, we found that among the mea-
sured species, SM 16:0 and 24:1 were the most abundant. Indeed,
these two species have been shown to be the most abundant in
many cellular types and tissues (Fitzgerald et al., 1995; Venable
et al., 1995; Bielawska et al., 2000; Merrill et al., 2005; Kono et al.,
2006; Valsecchi et al., 2007; Jin et al., 2008a). Importantly, LC–MS
results showed that SM 16:0 was signiﬁcantly elevated at day 12
of infection compared to un-infected mice (Figure 7) but not at
a later time point, as we observed in CBA/J mice. These results
suggest that the production of this sphingolipid might be inde-
pendent of T cell activation in immunocompromised mice but
only at early time points of infection. In fact, the basal levels of SM
16:0 in Tgε26 un-infected lung (Figure 8) was similar to the levels
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FIGURE 7 | Effect of C. neoformans infection on the level of SM 16:0 in
lungs of mice lacking NK andT cells. Lungs of Tgε26 mice un-infected and
infected with C. neoformans wild-type H99 strain were processed for MALDI
tissue imaging. Sphingomyelin (SM) 16:0 species ([M+Na]+ m/z 725) is
distributed throughout the lungs at all timepoints. Min and Max, minimum
and maximum intensity of SM 16:0 in the lung, respectively.
FIGURE 8 | Quantitative analysis of the lung sphingolipids upon
C. neoformans infection. Liquid Chromatography–Mass Spectrometry
(LC–MS/MS) analysis of immunocompromised mouse lungs infected with
wild-type C. neoformans show that SM 16:0 is the major species elevated
at the site of infection. Other SM species remain constant or are not
detected.
found in CBA/J un-infected lung (Qureshi et al., 2010). We could
not detect any SM 14:0, 26:0, or 26:1, suggesting that these species
are either not produced by cells found in the mouse lung or that
their levels are too low to be detected by MS.
DISCUSSION
In this investigation, the effect of pre-incubation of C. neoformans
with HL-60 derived neutrophils has been studied. Our results
show that pre-incubation of neutrophils with live but not heat-
killed C. neoformans inhibits any further killing by secreted ACFs.
Furthermore, activation of SMS in neutrophils, which is respon-
sible for modulating their killing activity, appears to be partially
independent of T and/or NK cell activation.
Neutrophils play important roles in host defense against all
classes of infectious agents including C. neoformans. They consti-
tute the second line of defense against pathogens after alveolar
macrophages because, once an inﬂammatory response is initi-
ated, neutrophils are the ﬁrst cells to be recruited to the site of
infection (Schleimer et al., 1989). Themicrobicidal arsenal of neu-
trophils includes the formation of reactive oxygen and nitrogen
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species, hydrolytic enzymes, and antimicrobial peptides, all of
which target microbes (Smith, 1994). Neutrophils can also kill
extracellular pathogens via the formation of neutrophil extracel-
lular traps (NETs), which have activity against C. albicans and
Aspergillus fumigatus (Urban et al., 2006a,b; Bruns et al., 2010).
Notably, neutrophils are more effective killers of C. neoformans
than macrophages, and they possess the innate ability to kill
microbes without a cell-mediated activation. So while it has long
been appreciated that neutrophils kill C. neoformans in part via
generation of fungicidal oxidants, non-oxidative mechanisms also
make a signiﬁcant contribution (Mambula et al., 2000). Interest-
ingly, transfusion of human neutrophils signiﬁcantly improved
the survival of mice challenged with fungal organisms (Spellberg
et al., 2005, 2007), suggesting that these cells are able to control the
infection through their antifungal activity.
To gain a better understanding of the neutrophil–C. neoformans
interaction,and speciﬁcally the interactionof ACFs secreted bydif-
ferentiatedHL-60 (HL-60D) cells into themedium,we turned our
attention to several in vitro systems. Before studying the response
of neutrophils upon C. neoformans challenge however, we veriﬁed
that the viability of HL-60 derived neutrophils used in this study
is not reduced upon exposure to C. neoformans, as is the case with
C. albicans where viability in the HL-60 granulocytic population
is signiﬁcantly affected (Mullick et al., 2004) upon phagocytosis
of C. albicans by neutrophils, which in turn induces the HL-60
derived neutrophils to undergo apoptosis. In the case of C. neofor-
mans, we have shown that killing is induced through the release of
ACFs instead of phagocytosis (Qureshi et al., 2010). This suggests
that, in contrast toC. albicans,C. neoformans cells may have devel-
oped other mechanisms to protect themselves against the killing
activity of neutrophils. Thus, we sought to determine whether C.
neoformans would be able to neutralize the antifungal action of
the medium.
Interestingly, secretion of the ACFs by HL-60 derived neu-
trophils into themedium,and subsequent killing of C. neoformans,
is maximal at 6 h. However, co-incubation of HL-60D cells with
C. neoformans shows maximal killing at 1 h (Figure 3), followed
by steady-state killing at 2 and 4 h, and no killing at 6 h, at which
time it is known that C. neoformans cells start doubling in RPMI
(Miller and Mitchell, 1991). Therefore 4 h was chosen as the time
point for C. neoformans killing by HL-60D medium. Surprisingly,
when the medium of HL-60D cells is used for further killing
of C. neoformans, after the preliminary C. neoformans–HL-60D
co-incubation, percent killing is severely reduced, implying that
co-incubation of HL-60D cells with C. neoformans decreases the
killing ability of the ACF in the medium, either because some C.
neoformans binds such factors and thus neutralizes them and/or
because C. neoformans degrades such factors. Thus C. neoformans
appears to play a pivotal role in the killing-degradation cycle of
the ACFs. The presence of the pathogen induces neutrophils to
kill C. neoformans, but degradation of the ACFs which are secreted
into the medium by neutrophils is also driven by the presence of
C. neoformans. This observation is supported by studies showing
that C. neoformans is able to secrete a variety of proteins including
proteases (Eigenheer et al., 2007). In order to better understand
this interaction, we sought to explore speciﬁcally the effect of C.
neoformans virulence factors upon the ACFs.
The antiphagocytic polysaccharide capsule and melanin are
important virulence components of C. neoformans. The regula-
tion of these virulence factors has been reviewed recently in several
excellentworks (Li andMody,2010;Alspaugh et al., 2011; Fox et al.,
2011; Idnurm et al., 2011; Nielsen and Kwon-Chung, 2011; Pfaller
et al., 2011). Interestingly, the presence of capsule made little to
no difference on killing of C. neoformans by the ACF in HL-60D
medium. Notably, the acapsular strain C. neoformans Δcap59 was
more resistant to killing by ACF, regardless of growth conditions.
This is likely due to the fact that despite lacking a polysaccharide
capsule and the protective architecture conferred upon it by the
main capsular components, C. neoformans Δcap59 has a thicker
cell wall which may provide some resistance to killing. Melanin
on the other hand confers excellent resistance to C. neoformans
against ACFs in the HL-60D medium.
Inositol phosphoryl ceramide synthase 1 (Ipc1) is a fungal
enzyme that transfers inositol phosphate from phosphatidyli-
nositol (PI) to phytoceramide, producing IPC and diacylglycerol
(DAG; Kuroda et al., 1999; Heidler and Radding, 2000). Once
produced, IPC is metabolized by Isc1 (Dickson and Lester, 1999;
Henry et al., 2011), and, by doing so, it regulates the levels of
complex sphingolipids and very long chain phytoceramides in C.
neoformans (Shea et al., 2006; Garcia et al., 2008; Tommasino et al.,
2008; Henry et al., 2011). Thus, we wished to examine the effect
of the modulation of these sphingolipids on killing under condi-
tions where Ipc1 was downregulated or Isc1 deleted. Loss of Isc1
leads to an accumulation of complex sphingolipids and a speciﬁc
depletion of phytoceramide C26,whereas no changes are observed
with phytoceramide C18 or other subspecies (Garcia et al., 2008).
Downregulation of Ipc1 (GAL7::IPC1, grown in glucose) shows
less complex sphingolipids, no change in phytoceramide C26 and
accumulation of C18 phytoceramides compared to theWT strain.
The observation that the GAL7::IPC1 strain (which contains
less inositol sphingolipids) is less susceptible to the killing activity
of neutrophils would argue that the presence of complex sphin-
golipids may favor the action of the ACFs present in the medium.
However, the fact that accumulation of complex sphingolipids
(Δisc1) does not render the cells more susceptible than the wild-
type does not support this hypothesis. On the other hand, the
increased resistance to killing by neutrophils may be due to accu-
mulation of phytoceramide C18 (observed in the GAL7::IPC1
strain). This hypothesis is supportedby the results showing that the
Δgcs1 strain is slightly more resistant and, in this strain, ceramide
C18 accumulates (Rittershaus et al., 2006). Taken together with
the results of the Δisc1 strain where no change in phytoceramide
(or ceramide) C18 correlates with no change in susceptibility,
this would support the hypothesis that phytoceramide C18 and
ceramide C18 play a role in resistance.
In continuation of our work on the role of host SMS in the reg-
ulation of the killing activity of neutrophils against C. neoformans,
we investigated whether neutrophils derived from immunocom-
promised mice would still kill C. neoformans. Neutrophils from
transgenic epsilon 26 mice (Tgε26), deﬁcient in NK cells and
T cells, were used to explore the killing of C. neoformans WT.
Macrophages, monocytes, and granulocytes are present and func-
tional in these mice (Wang et al., 1994, 1997). NK cells consti-
tute a major component of the innate immune system and are
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responsible for release of cytoplasmic granules that kill pathogen
cells, whereas T cells play a major role in CMI. The fact that neu-
trophils from Tgε26 mice were able to kill C. neoformans despite
lacking T cells implies that activation of SMS in the host is partially
independent of T and/or NK cells.
Finally, using MALDI–MS imaging of lung tissue from Tgε26
mice infected with C. neoformans WT we observed that SM 16:0
is found in the immunocompromised mouse lung similarly as in
the immunocompetent lung, suggesting that NK and/or T cells are
not necessary to produce a basal level of SM 16:0. When the lungs
were infected with C. neoformans though, we found that SM 16:0
was elevated only at day 12 of the infection and its overall dis-
tribution was much less organized in the immunocompromised
compared to the immunocompetent host, suggesting that T and/or
NK cells may have a role in activating SMS in the lung, and coor-
dinating the SMS response of neutrophils against C. neoformans,
especially when the infection progresses. It has been suggested
that sphingolipid-rich microdomains form platforms for the reg-
ulation and transduction of T cell receptors which cluster at the
center of the T cell-antigen presenting cell interface during T
cell activation. T cell clustering was shown to be impaired in an
SMS knockdown cell line (Jurkat-SMS1/kd), indicating that SM
and hence SMS may be important for full T cell activation (Jin
et al., 2008b), and in the case where T cells are lacking, SMS will
be somewhat impaired as one of its regulatory functions will be
curtailed.
In conclusion, we have shown that pre-incubation of live but
not heat-killed C. neoformans inhibits further killing activity of
ACFs. Neither the presence of C. neoformans nor the capsule size
has any effect on neutrophil viability but melanin confers resis-
tance to C. neoformans against neutrophil killing. Finally SMS
activation in neutrophils may be independent of T cell and/or NK
cells activation.
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